News Ticker

Argonaut Manufacturing Services acquires lyophilization expert LyoGen

Argonaut Manufacturing Services, a contract development and manufacturing organization (CDMO) serving molecular diagnostic and biopharmaceutical companies, today announced it has reached a definitive agreement to acquire LyoGen LLC. Terms of the transaction were not disclosed.

LyoGen’s services provides lyophilized products in unique, proprietary formats, including unit dose LyoDose™ beads, microbeads, deposition, and bulk products delivered in vials and powder formats.

With the acquisition of LyoGen, Argonaut expands its reagent lyophilization capabilities from process development through production scale deployment.

“We have been impressed with both the depth and expertise in LyoGen’s lyophilization capabilities. LyoGen’s commitment to client satisfaction, transparency and agility are highly aligned with our values at Argonaut. The LyoGen team has created a unique offering in the lyophilization market that complements Argonaut’s commitment to assisting innovators with their outsourced manufacturing needs,” said Wayne Woodard, Chief Executive Officer of Argonaut. “LyoGen’s decades of lyophilization experience offers Argonaut’s clients a tailored solution. We are pleased to welcome the talented LyoGen team to the Argonaut family.”

“We believe the combination of Argonaut and LyoGen capabilities creates a highly attractive and comprehensive platform for organizations seeking cost efficiencies, reducing cold chain requirements, and those developing user-friendly products,” said Mark Nowakowski, Chief Executive Officer and founder of LyoGen. “Together, Argonaut and LyoGen put quality as a top priority and we believe this deal gives our LyoGen customers the resources they have been requesting, and will deliver a more comprehensive solution.”

About Argonaut Manufacturing Services

Argonaut Manufacturing Services is a Contract Development and Manufacturing Organization (CDMO) located in Carlsbad, California serving the Molecular Diagnostic and BioPharma industries. The company offers registered cGMP/ISO 13485:2016 support to a wide variety of innovators looking for high quality, superior flexibility, and cost effectiveness from their contract manufacturing partner. More information is available at

About LyoGen

LyoGen LLC (formally known as BioMatrix Engineering) was founded in 2001 and its core technology was developed by its founder in 1990. LyoGen develops proprietary lyophilized products in many different formats, including unit dose LyoDose™ beads, microbeads, deposition and bulk products delivered in vials and powder formats.

Leave a comment

Your email address will not be published.